Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by Litemuppon Dec 06, 2016 1:38pm

79 Views

Post# 25561164

RE:at some point the holiday season kicks in

My cut off date is Dec 14. After that I sell half my positions and hold cash over the holidays season.

Busyzzindahouse wrote: I havent been invested in mj stocks long enough to know what happened last year in december........ for most sectors, at some point in december, the market slows down to a crawl and a lot of investors pull money out of speculative plays to hold cash over the holiday season...... was it the same for the Mj plays last year......... honest responses only plssss

Bullboard Posts

Unique Battery Metals opportunity in Quebec